Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase 1 2 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 222 Carboplatin 216 Cisplatin 204 Paclitaxel 181 Gemcitabine 148 Docetaxel 125 Capecitabine 114 Dexamethasone 102 Cyclophosphamide 102 Pemetrexed 101 Specimen Handling 99 Magnetic Resonance Spectroscopy 97 Oxaliplatin 95 Radiotherapy 94 Doxorubicin 90 Fluorouracil 87 Bevacizumab 82 Nivolumab 73 Leucovorin 72 Rituximab 70 durvalumab 66 Vincristine 66 Lenalidomide 64 Etoposide 61 atezolizumab 59 Radiation 59 Irinotecan 59 130-nm albumin-bound paclitaxel 56 Prednisone 55 Letrozole 52

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Valacyclovir × 1 year × Clear all

NCT01436968 2025-07-30

PrTK03

Candel Therapeutics, Inc.

Phase 3 Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡